Stock Code: 301234 Stock Abbreviation: Wuzhou Medical Listing Venue: Shenzhen Stock Exchange
[Image: Company Logo]
Anhui Hongyu Wuzhou Medical Instrument Co., Ltd.
Summary of the Draft Plan for Issuing Shares and Paying Cash to Purchase Assets and Raising Supporting Funds and Related Party Transactions
| Project | Name |
|---|---|
| Counterparties for asset purchase | Liu Gang, Wang Yongjiang, Suzhou Xindongneng Technology Venture Capital Partnership (Limited Partnership), Gao Bingqiang, Lü Huang, Jiangsu Jiquan Yuanhe Puhua Equity Investment Partnership (Limited Partnership), Hui Capital Glory Limited, Ever Zone International Limited, Lu Feng, Shanghai Zhangjiang Suifeng Innovation Equity Investment Fund Partnership (Limited Partnership), Huichuang (Shenzhen) Private Equity Fund Management Co., Ltd., FNOF Harvest City Limited, and 34 other counterparties |
| Subscribers for supporting funds | No more than 35 qualified specific investors |
Signing Date: July 2026
Statement of the Listed Company
The Company and all directors and senior management guarantee that the contents of this draft plan and its summary are true, accurate, and complete, and contain no false records, misleading statements, or major omissions. If losses are caused to investors due to false records, misleading statements, or major omissions in the provided information, explanations, or confirmations, they shall bear the corresponding legal liabilities in accordance with the law.
The controlling shareholder, actual controller and their persons acting in concert, directors, and senior management of the Company undertake that if the information disclosed or provided by the undersigned in this transaction is suspected of containing false records, misleading statements, or major omissions, and is subject to case filing and investigation by judicial authorities or the China Securities Regulatory Commission, the undersigned will not transfer the shares held in the listed company until the investigation conclusion is formed. The undersigned shall submit a written application for suspension of transfer and the stock account to the board of directors of the listed company within two trading days of receiving the notice of case filing, and the board of directors shall apply for locking on behalf of the undersigned to the stock exchange and the securities registration and clearing institution. If the locking application is not submitted within two trading days, the board of directors is authorized to verify and directly report the identity and account information of the undersigned to the stock exchange and the securities registration and clearing institution to apply for locking. If the board of directors fails to report the information, the stock exchange and the securities registration and clearing institution are authorized to directly lock the relevant shares. If the investigation conclusion reveals illegal or non-compliant circumstances, the undersigned undertakes that the locked shares will be voluntarily used for compensation arrangements for relevant investors.
As of the signing date of this draft plan, the audit and evaluation work related to this transaction has not been completed. The relevant data of the target company involved in this draft plan and its summary have not been audited by an accounting firm or evaluated by an evaluation institution. All directors and senior management of the Company guarantee the authenticity and rationality of the relevant data cited in this draft plan and its summary. The audited financial data of the target company and the evaluation results of the evaluated assets will be disclosed in the reorganization report of this transaction.